Pain：针灸可有效预防偏头痛患和加重

记者从日前在京召开的2011年内经国际性研讨会上获悉，首都医科大学原为北京中医医院内经中心经临床数据分析确认，传统观念的中医内经疗法可适当防范痉挛的复发和再加。相关数据分析学术著作已对刊登在国际性著名医学期刊《痉挛》上，成为华南地区大陆首篇刊登于该杂志的临床数据分析学术著作。该文还被国际性知名医学遗传学机构 Faculty of 1000 medicine（千名外科医生）附有。

据认识，作为临床常见病之一，痉挛死亡率高，且危害相当严重。现在，法制18岁~65岁这群人的痉挛存活率高9.3%，且有逐年增大趋势。内经治疗法痉挛在华南地区仍未有数千年的历史。北京中医医院内经中心自2004年设立痉挛专家门诊，开展了基于“红叶王卢家”、国医魔术师贺普仁等多位著名内经学家治痛经验的痉挛数据分析。

据该中心主任王麟鹏介绍，该新项目采取单盲、双各种类型、随机对照的多种形式，在国际性间5家医院的内经科共招募140名无预兆痉挛患者，随机总称两小组，分别为治疗法小组（内经加安慰剂）和对照小组（假针加氟桂利嗪）。两小组患者每周内经治疗法3次，每晚口服药物。结果显示，4时更，治疗法小组痉挛的适当加剧率为59%，对照小组为40%；治疗法小组痉挛起算少于升高4.1天，对照小组少于升高1.9天。16时更，治疗法小组适当加剧率为56%，对照小组为37%；治疗法小组痉挛起算少于升高 4.1天，对照小组少于升高2天。

数据分析人员据此认为，内经可以作为痉挛的防范复发和再加的方式，其治果也优于此前境外的相关数据分析。由于其数据分析方式的新颖和重要性，该学术著作还被国际性知名医学遗传学机构“千名数据分析者”附有。（生物谷 Bioon.com）

doi:10.1016/j.pain.2011.04.006PMC:PMID:

Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial

Lin-Peng Wang,Xiao-Zhe Zhang,Jia Guo,Hui-Lin Liu,Yan Zhang,Cun-Zhi Liu,Jing-Hong Yi,Li-Ping Wang,Ji-Ping Zhao,Shan-Shan Li

Summary This multicenter, double-dummy trial suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks. Abstract Insufficient clinical trial data were ailable to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual ogue scale (VAS, 0 to 10cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.